Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elizabeth DiMaggio"'
Publikováno v:
Journal of Pediatric Neuropsychology. 6:44-60
An 8-year-old, Caucasian, and right-handed female presented for a baseline neuropsychological evaluation due to diagnosis of electrical status epilepticus during sleep (ESES) preceded by postictal, late-night discovery of the patient on the floor and
Autor:
Anthony C. Wood, Ariel Perez Perez, Brian Arciola, Kedar Patel, Grace Johnson, Elizabeth DiMaggio, Christina A. Bachmeier, Kayla Reid, Salvatore Carallo, Melanie H. Vargas, Rawan Faramand, Julio C. Chavez, Bijal Shah, Sameh Gaballa, Farhad Khimani, Hany Elmariah, Taiga Nishihori, Aleksandr Lazaryan, Ciara Freeman, Marco L. Davila, Frederick L. Locke, Rahul Mhaskar, Claude Bassil, Michael D. Jain
Publikováno v:
Transplantation and Cellular Therapy. 28:829.e1-829.e8
Patients with renal impairment (RI) are typically excluded from trials evaluating chimeric antigen receptor (CAR) T cell therapies. We evaluated the outcomes of patients with RI receiving standard of care (SOC) CAR T cell therapy for relapsed/refract
Autor:
Anthony C Wood, Brian Arciola, Kedar Patel, Grace Johnson, Ariel Perez Perez, Christina A Bachmeier, Elizabeth DiMaggio, Julio C. Chavez, Bijal Shah, Sameh Gaballa, Farhad Khimani, Taiga Nishihori, Aleksandr Lazaryan, Ciara Freeman, Marco L. Davila, Frederick L. Locke, Rahul Mhaskar, Claude Bassil, Michael D Jain
Publikováno v:
Transplantation and Cellular Therapy. 28:S194-S195
Autor:
Elizabeth DiMaggio
Publikováno v:
PharmacotherapyReferences. 40(8)
Acute graft-versus-host disease remains a devastating complication following hematopoietic cell transplantation, resulting in increased morbidity and mortality. Vast research efforts continue to refine or develop new means of prediction, assessment,
Autor:
Ryan J. Caddell, Brian C. Betts, Jun-Min Zhou, Janelle Perkins, Farhad Khimani, Taiga Nishihori, Asmita Mishra, Joseph Pidala, Elizabeth DiMaggio, Claudio Anasetti, Lia Perez, Hugo F. Fernandez, Rebecca Tombleson
Publikováno v:
Leukemialymphoma. 61(7)
Optimal conditioning chemotherapy for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) remains uncertain. Myeloablative regimens such as fludarabine/busulfan are favored over reduced-intensity fludarabine/melphalan (Flu/M
Autor:
Farhad Khimani, Taiga Nishihori, Michael Nieder, Jose Laborde, Rebecca Gonzalez, Hany Elmariah, Hien Liu, Rawan Faramand, Joseph Pidala, Aliyah Baluch, Nelli Bejanyan, Aleksandr Lazaryan, Jongphil Kim, Lia Perez, Jose L. Ochoa-Bayona, Daniel C. Sullivan, Elizabeth DiMaggio, Asmita Mishra
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S189
Introduction Mycophenolate mofetil (MMF) dose/kg can influence clinical outcomes of allogeneic hematopoietic cell transplantation (HCT) including acute graft-versus-host disease (GVHD) (Harnicar BBMT 2015; Bejanyan BBMT 2018). When used for GVHD prop
Autor:
Alexandre Tungesvik, Ankita Tandon, Praneeth Reddy Sudalagunta, Elizabeth Dimaggio, Katherine Tobon, Rebeccah Nelson, Laura Olson, Jessica Huang, Kenneth H. Shain, Gabe De Avila, Jason Brayer
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S327-S328
Autor:
Ankita Tandon, Praneeth Reddy Sudalagunta, Gabe De Avila, Katherine Tobon, Elizabeth Dimaggio, Kenneth H. Shain, Laura Olson, Alexandre Tungesvik, Jessica Huang, Jason Brayer, Rebecca A. Nelson
Publikováno v:
Journal of Clinical Oncology. 37:e19513-e19513
e19513 Background: Although there is much to be optimistic about in the multiple myeloma community as the approval of new therapies and regimen-combinations for relapsed refractory disease continues to grow, determining the best option for a patient
Autor:
Elizabeth DiMaggio, Asmita Mishra, Brian C. Betts, Farhad Khimani, Taiga Nishihori, Braydon Schaible, Rebecca Tombleson, Zhenjun Ma, Lia Perez, Hugo F. Fernandez, Joseph Pidala, Ernesto Ayala, Claudio Anasetti
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S290
Autor:
Joseph Pidala, Ernesto Ayala, Zhenjun Ma, Rebecca Tombleson, Brian C. Betts, Taiga Nishihori, Frederick L. Locke, Ryan J. Caddell, Braydon Schaible, Claudio Anasetti, Elizabeth DiMaggio, Hugo F. Fernandez, Asmita Mishra, Mohamed A. Kharfan-Dabaja
Publikováno v:
Blood. 128:3486-3486
Introduction: Fludarabine (Flu)-based conditioning regimens, combined with either melphalan (Mel) or intravenous busulfan (Bu), are often utilized in patients undergoing allogeneic hematopoietic cell transplantation (HCT) for acute myeloid leukemia (